Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Shangzi Wang
Effective Antibody Therapy Induces Host-Protective Antitumor Immunity That Is Augmented by TLR4 Agonist Treatment
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
Related publications
Influenza Virus-Like Particles Engineered by Protein Transfer With Tumor-Associated Antigens Induces Protective Antitumor Immunity
Biotechnology and Bioengineering
Applied Microbiology
Biotechnology
Bioengineering
Gene Therapy With Beta-Defensin 2 Induces Antitumor Immunity and Enhances Local Antitumor Effects
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Neisseria Meningitidis GNA2132, a Heparin-Binding Protein That Induces Protective Immunity in Humans
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
AVibrio Choleraeghost-Based Subunit Vaccine Induces Cross-Protective Chlamydial Immunity That Is Enhanced by CTA2B, the Nontoxic Derivative of Cholera Toxin
FEMS Immunology & Medical Microbiology
Intradermal Immunization of Mice With Radiation-Attenuated Sporozoites of Plasmodium Yoelii Induces Effective Protective Immunity
Malaria Journal
Parasitology
Infectious Diseases
Flagellin Induces Innate Immunity in Nonhost Interactions That Is Suppressed by Pseudomonas Syringae Effectors
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
A Cancer Therapeutic Vaccine Based on Clustered Tn-Antigen Mimetics Induces Strong Antibody-Mediated Protective Immunity
Angewandte Chemie
Toxicity of an Fc-Engineered Anti-Cd40 Antibody Is Abrogated by Intratumoral Injection and Results in Durable Antitumor Immunity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Combination Therapy With Dendritic Cells and Lenalidomide Is an Effective Approach to Enhance Antitumor Immunity in a Mouse Colon Cancer Model
Oncotarget
Oncology
